Peter J. J. Goadsby, MBBS, MD, PhD, DSc, FRACP, FRCP

Professor of Neurology
King’s College London; University of California, Los Angeles
London, England, United Kingdom

Disclosure information not submitted.

Presentation(s):

• Efficacy of Ubrogepant for the Treatment of Migraine Symptoms During the Prodrome (Premonitory Phase): Results From the PRODROME Trial

  POSTER ABSTRACT

• Ubrogepant for the Acute Treatment of Migraine When Administered During the Prodrome (Premonitory Phase): Results From a Phase 3, Randomized, Double-blind, Placebo-Controlled, Crossover Study

  POSTER ABSTRACT